GB2602123B - Composition for procedural sedation and use thereof - Google Patents
Composition for procedural sedation and use thereof Download PDFInfo
- Publication number
- GB2602123B GB2602123B GB2020153.9A GB202020153A GB2602123B GB 2602123 B GB2602123 B GB 2602123B GB 202020153 A GB202020153 A GB 202020153A GB 2602123 B GB2602123 B GB 2602123B
- Authority
- GB
- United Kingdom
- Prior art keywords
- composition
- procedural sedation
- sedation
- procedural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2020153.9A GB2602123B (en) | 2020-12-18 | 2020-12-18 | Composition for procedural sedation and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2020153.9A GB2602123B (en) | 2020-12-18 | 2020-12-18 | Composition for procedural sedation and use thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
GB202020153D0 GB202020153D0 (en) | 2021-02-03 |
GB2602123A GB2602123A (en) | 2022-06-22 |
GB2602123B true GB2602123B (en) | 2023-08-16 |
Family
ID=74221197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2020153.9A Active GB2602123B (en) | 2020-12-18 | 2020-12-18 | Composition for procedural sedation and use thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2602123B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016102463A1 (en) * | 2014-12-23 | 2016-06-30 | Bosteels Arnaud | Combination of remifentanil and propofol |
-
2020
- 2020-12-18 GB GB2020153.9A patent/GB2602123B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016102463A1 (en) * | 2014-12-23 | 2016-06-30 | Bosteels Arnaud | Combination of remifentanil and propofol |
Non-Patent Citations (9)
Also Published As
Publication number | Publication date |
---|---|
GB2602123A (en) | 2022-06-22 |
GB202020153D0 (en) | 2021-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202106282D0 (en) | Composition and use thereof | |
EP4063489A4 (en) | Composition and use thereof | |
EP4138879A4 (en) | Methods and compositions | |
EP4084784A4 (en) | Compositions and methods | |
EP4134068A4 (en) | Bendamustine composition and use thereof | |
GB202004677D0 (en) | Methods and compositions | |
GB2602123B (en) | Composition for procedural sedation and use thereof | |
EP4181941A4 (en) | Compositions and uses thereof | |
FI4103161T3 (en) | Compositions and uses thereof | |
GB202014160D0 (en) | Senolytic compounds and compositions | |
GB202102228D0 (en) | Composition and use thereof | |
GB202014427D0 (en) | Composition and use | |
GB202107254D0 (en) | Compositions and use thereof | |
GB202016697D0 (en) | Compound and composition for use | |
GB202106861D0 (en) | Composition and uses | |
GB202114798D0 (en) | New uses and compositions | |
GB202016094D0 (en) | New compositions and uses thereof | |
GB202111289D0 (en) | Compositions and uses thereof | |
GB202110657D0 (en) | Compositions and uses thereof | |
GB202107615D0 (en) | Compositions and uses thereof | |
GB202107614D0 (en) | Compositions and uses thereof | |
GB202107399D0 (en) | Compositions and uses thereof | |
GB202105108D0 (en) | Compositions and uses thereof | |
GB202018414D0 (en) | Compositions and uses thereof | |
GB202016492D0 (en) | Compositions and uses thereof |